Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial metalloenzymes are a broad class of enzymes found in bacteria (especially gut microbes) that require metal ions such as iron, zinc, copper, manganese, molybdenum, cobalt, or nickel as essential cofactors for catalytic activity[1][2][7][8]. These enzymes perform diverse and critical biochemical functions, including redox transformations, detoxification, degradation of dietary and host-derived small molecules, and maintenance of microbial metabolism in oxygen-limited environments[1][2][7]. They enable microbes to use alternative nutrients and modulate the bioactivity of compounds relevant to host health (including neurotransmitters and xenobiotics)[9]. Microbial metalloenzymes are prevalent in human-associated microbiota and have significant implications for drug metabolism, pathogenesis, and disease modulation[1][2][9]. Because they play central roles in microbial survival and interaction with the host, they are emerging as important targets for therapeutic intervention, including in the development of antimicrobial agents that inhibit metalloenzyme activity[5][6]. However, "microbial metalloenzymes" is a collective and non-specific term covering a large and heterogeneous group of enzyme families, rather than a single molecular target, which should be noted when considering drug targeting or biomarker discovery[1][2][5]. Key notes for structuring information: - The term "microbial metalloenzyme" does not refer to a single molecular entity but a group/family of targets; specific examples (such as molybdenum-dependent catechol dehydroxylase, superoxide dismutases, metallo-β-lactamases, etc.) can be referenced for more granular data[1][3][9]. - Appropriate canonical names should be used when focusing on individual enzymes within the broader class. - The field is of high biomedical relevance, especially for antibiotic development and modulation of the gut microbiome[1][2][5]. Is_incorrect rationale: The provided target is not a single gene/protein but an entire class, so the entry lacks the specificity required of most molecular targets. It is too broad to map to an individual canonical form[1][2][5].
Inhibition of metal binding; Blockade of catalytic activity; Deprivation of essential metal cofactors
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial metalloenzyme.